| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/09/2006 | EP1687023A2 Use of specific histones for the treatment of parasitic diseases |
| 08/09/2006 | EP1687022A2 Renta: an hiv immunogen and uses thereof |
| 08/09/2006 | EP1687016A2 Diphtheria toxin variant |
| 08/09/2006 | EP1687012A1 Stabilisation of viral microparticles |
| 08/09/2006 | EP1687011A2 Modified whole cell, cell extract and omv-based vaccines |
| 08/09/2006 | EP1686970A2 Use of an inhibitor of csf-1 activity for the treatment of inflammatory bowel disease |
| 08/09/2006 | EP1686961A1 Solid forms of anti-egfr-antibodies |
| 08/09/2006 | EP1686904A2 Ultrasound assisted transdermal vaccine delivery method and system |
| 08/09/2006 | EP1553977B1 Vaccine against infections caused by oncoviruses such as the feline leucosis virus of cats |
| 08/09/2006 | EP1423429B1 Antibodies against caspase-8, their preparation and use |
| 08/09/2006 | EP1387693B1 Saponin inactivated mycoplasma vaccine |
| 08/09/2006 | EP1372741B1 Morpholino imaging and therapy |
| 08/09/2006 | EP1183275B1 Specific antibodies against human chorionic gonadotropin and their use in therapy and diagnostic |
| 08/09/2006 | EP1171157B1 Use of glucose-6-phospate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds |
| 08/09/2006 | EP1146900B1 Dna vaccines against hantavirus infections |
| 08/09/2006 | EP1144003B1 Methods and devices for delivery of agents to breast milk ducts |
| 08/09/2006 | EP1077722B1 Methods and products for inducing mucosal immunity |
| 08/09/2006 | EP1069135B1 Proteins having immunomodulatory activity and remedies for immunological diseases |
| 08/09/2006 | EP1066053B1 Hib/dtpa vaccine composition and methods of preparation |
| 08/09/2006 | EP1044014B1 Agent for treating allergic or hypersensitivity condition |
| 08/09/2006 | EP1037650B1 Compositions for the treatment of staphylococcus aureus infections |
| 08/09/2006 | EP1007092B1 A process for inhibiting complement activation via the alternative pathway |
| 08/09/2006 | EP1005487B1 The 74 kilodalton outer membrane protein from moraxella catarrhalis |
| 08/09/2006 | EP0910659B1 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections |
| 08/09/2006 | EP0827513B1 Reagents for treatment and diagnostic visualisation, particularly in cancer |
| 08/09/2006 | EP0759988B1 NUCLEIC ACIDS OF $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) AND METHODS AND COMPOSITIONS FOR DIAGNOSING $i(ROCHALIMAEA HENSELAE) AND $i(ROCHALIMAEA QUINTANA) INFECTION |
| 08/09/2006 | EP0752004B1 Recombinant adenoviruses coding for glial-derived neurotrophic factor (gdnf) |
| 08/09/2006 | EP0724642B1 Nucleotide vector, composition containing such vector and vaccine for immunization against hepatitis |
| 08/09/2006 | CN1816567A Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease |
| 08/09/2006 | CN1816524A Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/09/2006 | CN1816352A Methods for treating cancer using an immunotoxin |
| 08/09/2006 | CN1816351A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 08/09/2006 | CN1816350A Mucosal vaccines with chitosan adjuvant and/or meningococcal antigens |
| 08/09/2006 | CN1816349A Compositions and methods for WT1 specific immunotherapy |
| 08/09/2006 | CN1816348A Improved heat shock protein-based vaccines and immunotherapies |
| 08/09/2006 | CN1814757A Novel CpGDNA adjurar, its preparing method and vaccine containing same |
| 08/09/2006 | CN1814619A Chimeric antigen for preventing, diagnozing and treating respiratory syncytial virus infection and its antibody |
| 08/09/2006 | CN1814301A Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same |
| 08/09/2006 | CN1814287A Prevention and treatment of amyloidogenic disease |
| 08/09/2006 | CN1814286A B-type hepatitis and E-type hepatitis combined vaccine and preapring method |
| 08/09/2006 | CN1814285A Vaccine composition for treating B-type hepatitis and preparing method |
| 08/09/2006 | CN1813678A Hepatitis B vaccine liposome and its trans dermal drug delivery system |
| 08/09/2006 | CN1268748C Viral vaccine |
| 08/09/2006 | CN1268747C Recombinant newcastle disease virus RNA expression systems and vaccines |
| 08/09/2006 | CN1268745C Group B streptococcus antigens |
| 08/09/2006 | CN1268743C genetic construct for coding cell targeting part and heterologous precursor activating enzyme, and its application |
| 08/09/2006 | CN1268738C Cytoxtoxic T lymphocytes |
| 08/09/2006 | CN1268645C Therapeutic compounds comprised of anti-FC receptor binding agents |
| 08/09/2006 | CN1268644C Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline E to its high affinity receptor |
| 08/09/2006 | CN1268643C Antibody against SARS-CoV IgY and its preparing method |
| 08/09/2006 | CN1268642C Yelk antibody specific for preventing pigling diarrhea and its preparing method and application |
| 08/09/2006 | CN1268637C I (chlamydia) protein, gene sequence and uses thereof |
| 08/09/2006 | CN1268394C Binding domain-immunoglobulin fusion proteins |
| 08/09/2006 | CN1268393C Improved modified live BRSV vaccine |
| 08/09/2006 | CN1268392C Vaccine of recombined albumen for preventing and treating infection of human C type hepatitis virus and its usage |
| 08/09/2006 | CN1268345C Method of treating hepatitis delta viral infection |
| 08/08/2006 | US7087741 Nucleic acids encoding novel proteins in enteroaggregative escherichia coli (EAEC) |
| 08/08/2006 | US7087728 Crystal proteins which display stability to harsh environmental conditions; pronase resistance |
| 08/08/2006 | US7087726 Anti-interferon-α antibodies |
| 08/08/2006 | US7087725 Antibodies specifically reactive with a tumor necrosis factor related ligand |
| 08/08/2006 | US7087724 Carrier molecules |
| 08/08/2006 | US7087718 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 08/08/2006 | US7087715 Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses |
| 08/08/2006 | US7087713 Polypeptides that contain at least one immunogenic portion of one or more Mycobacterium proteins and DNA encoding said proteins |
| 08/08/2006 | US7087712 Peptide for triggering an immune reaction against tumor cells |
| 08/08/2006 | US7087600 Anticancer agents; side effect reduction |
| 08/08/2006 | US7087585 Tripeptide of FcγRIIA |
| 08/08/2006 | US7087574 Brain associated inhibitor of tissue-type plasminogen activator |
| 08/08/2006 | US7087425 Method of purifying oocysts using enzymatic digestion of fecal debris |
| 08/08/2006 | US7087413 Hyaluronan synthase gene and uses thereof |
| 08/08/2006 | US7087410 Expression vector for transformation and expression of heterologous polypeptides in methylococcal/methanotrophic bacteria; bioreactors |
| 08/08/2006 | US7087405 Anticancer agents; rheumatic diseases; genetic engineered plasmid |
| 08/08/2006 | US7087377 Method and kit for detection of tat protein with anti-tat oyi antibodies |
| 08/08/2006 | US7087372 Compositions and methods for detection of Ehrlichia canis and Ehrlichia chaffeensis antibodies |
| 08/08/2006 | US7087245 Intracelluloar adhesion molecules |
| 08/08/2006 | US7087236 Parenterally administering to a subject microparticles comprising at least one antigen entrapped or encapsulated in a biodegradable polymer, wherein biodegradable polymer comprises a copolymer of lactic acid and glycolic acid or enantiomers |
| 08/08/2006 | US7087235 Fusion protein of streptococcal pyrogenic exotoxins |
| 08/08/2006 | US7087234 Recombinant multivalent viral vaccine |
| 08/08/2006 | US7087231 In situ diagnosis of malaria |
| 08/08/2006 | US7087230 Proteins in enteroaggregative escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/08/2006 | US7087229 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 08/08/2006 | US7087228 prevention or prophylaxis of dental caries and endocarditis comprising Streptococcus mutans Competence Stimulating Peptide and sucrose; minimizes the attachment of S. mutans to teeth, and consequently minimize the negative consequences |
| 08/08/2006 | US7087224 Method of treating anemia by administering IL-1ra |
| 08/08/2006 | US7087213 Method of preparing cow brain homogenate |
| 08/08/2006 | CA2110899C Orally administrable therapeutic proteins and method of making |
| 08/03/2006 | WO2006081576A2 Immunologically active compositions |
| 08/03/2006 | WO2006081372A2 Use of parasitic biological agents for prevention and control of allergic and other ige-mediated disorders |
| 08/03/2006 | WO2006081259A2 Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 08/03/2006 | WO2006081171A1 Humanized anti-amyloid antibody |
| 08/03/2006 | WO2006081139A2 Antibodies against interleukin-1 beta |
| 08/03/2006 | WO2006081007A2 Use of flagellin in tumor immunotherapy |
| 08/03/2006 | WO2006080867A1 Agent for stimulating the production of a blood coagulation factor viii |
| 08/03/2006 | WO2006080842A2 Oral vaccines for fish |
| 08/03/2006 | WO2006080483A1 Novel dendritic cell membrane molecule and dna encoding the same |
| 08/03/2006 | WO2006080420A1 Antigen-specific t cell inducer, antibody production inducer, immune enhancer and vaccine |
| 08/03/2006 | WO2006080340A1 Concomitant use of hepatitis c virus-origin peptide with interferon |
| 08/03/2006 | WO2006079989A2 Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines |
| 08/03/2006 | WO2006079291A1 Artificial synthetic single strand deoxynucleotide and vaccine composition thereof and the use |
| 08/03/2006 | WO2006079290A1 A recombinant sars-cov vaccine comprising attenuated vaccinia virus carriers |
| 08/03/2006 | WO2006079176A1 Molecules and chimeric molecules thereof |